used in conventional Chinese, Ayurvedic, and Thai medicine. Conolidine could depict the start of a whole new era of Continual pain management. It is now becoming investigated for its effects to the atypical chemokine receptor (ACK3). Within a rat product, it was uncovered that a competitor molecule binding to ACKR3 resulted in inhibition of ACKR3�